← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target (TLR4/NFKB1/NLRP3) — 7.20 Enteric Nervous System Dysfunction as Self-Reinforcing Patho (SNCA/GFAP/VIP/nNOS/CHAT) — 7.00 Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propa (SNCA/p-SNCA (Ser129)/GBA/LRRK2) — 6.00 SCFA Deficiency Disrupts Microglial Homeostasis and Promotes (HDAC3/GPR43 (FFAR2)/IL10/TREM2/OCLN) — 5.50 Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 TREM2-Dependent Microglial Senescence Transition (TREM2) — 0.95 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.95 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.94 PLCG2 Allosteric Modulation as a Precision Therapeutic for T (PLCG2) — 0.94 Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-00 (CSF p-tau217 (biomarker), lncRNA-0021, hUC-MSC exosomes) — 0.94 Multi-Biomarker Composite Index Surpassing Amyloid PET for T (COMPOSITE_BIOMARKER) — 0.93 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.93 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.92 CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli (CYP46A1) — 0.92 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 Selective Acid Sphingomyelinase Modulation Therapy (SMPD1) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 CYP46A1 Overexpression Gene Therapy (CYP46A1) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 SASP-Mediated Complement Cascade Amplification (C1Q/C3) — 0.91 TREM2-ASM Crosstalk in Microglial Lysosomal Senescence (SMPD1) — 0.91 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene (TREM2) — 0.91 Nutrient-Sensing Epigenetic Circuit Reactivation (SIRT1) — 0.91 Closed-loop focused ultrasound targeting EC-II SST interneur (SST) — 0.90 CSF1R Inhibition-Mediated Microglial Replacement as a State (CSF1R) — 0.90
Add
|
× SIRT3 Mitochondrial Activ × Microglial TREM2 Activati
SIRT3 Mitochondrial · connectomics · -
Composite 0.350
Price $0.35
Evidence For 0
Evidence Against 0
SIRT3 Mitochondrial Activation to Counter Hub-Specific Energetic Vulnerability
Microglial TREM2 · connectomics · -
Composite 0.510
Price $0.51
Evidence For 0
Evidence Against 0
Microglial TREM2 Activation to Enhance Synaptic Pruning Regulation
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Unspecified Mechanism connectomics
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 2/11
dimensions won
SIRT3 Mitochondrial Activation to Counte
10/11
dimensions won
Microglial TREM2 Activation to Enhance S
Radar Chart — 10 Dimensions
Score Breakdown
Dimension SIRT3 Mitochondrial Activation Microglial TREM2 Activation to Mechanistic 0.450 0.700 Evidence 0.300 0.650 Novelty 0.600 0.750 Feasibility 0.300 0.500 Impact 0.350 0.650 Druggability 0.200 0.550 Safety 0.500 0.400 Competition 0.500 0.550 Data 0.300 0.650 Reproducible 0.250 0.400 KG Connect 0.500 0.500
Evidence SIRT3 Mitochondrial Activation to Counter Hub-Specific Energ No evidence citations yet
Microglial TREM2 Activation to Enhance Synaptic Pruning Regu No evidence citations yet
Debate Excerpts SIRT3 Mitochondrial Activation to Counter Hub-Spec 4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Connectome Preservation in Alzheimer's Disease
## Hypothesis 1: Network-Directed Anti-Amyloid Immunotherapy via Transcranial Focused Ultrasound
**Description:** Tra...
Skeptic
# Critical Evaluation of Connectome Preservation Hypotheses in Alzheimer's Disease
## Overview Assessment
These seven hypotheses collectively represent a sophisticated network-level approach to AD...
Domain Expert
# Expert Evaluation: Connectome Preservation Hypotheses in Alzheimer's Disease
## Drug Development Reality Check
I will evaluate each hypothesis against practical criteria: target tractability, ch...
Synthesizer
# Connectome Preservation Hypotheses - Synthesis Analysis
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": 6,
"title": "Microglial TREM2 Activation to Enhance Synaptic Pr...
Microglial TREM2 Activation to Enhance Synaptic Pr 4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Connectome Preservation in Alzheimer's Disease
## Hypothesis 1: Network-Directed Anti-Amyloid Immunotherapy via Transcranial Focused Ultrasound
**Description:** Tra...
Skeptic
# Critical Evaluation of Connectome Preservation Hypotheses in Alzheimer's Disease
## Overview Assessment
These seven hypotheses collectively represent a sophisticated network-level approach to AD...
Domain Expert
# Expert Evaluation: Connectome Preservation Hypotheses in Alzheimer's Disease
## Drug Development Reality Check
I will evaluate each hypothesis against practical criteria: target tractability, ch...
Synthesizer
# Connectome Preservation Hypotheses - Synthesis Analysis
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": 6,
"title": "Microglial TREM2 Activation to Enhance Synaptic Pr...
Price History Overlay
Knowledge Graph Comparison
SIRT3 Mitochondrial Activation to Counte
5 edges
Top Relations implicates_in 5
Microglial TREM2 Activation to Enhance S
5 edges
Top Relations implicates_in 5